WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Stock Ownership - Who owns Lenz Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lenz Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Versant Venture Capital VI LP10% Owner2025-06-10350,000$29.00
$10.15MSell
Shawn OlssonChief Commercial Officer2025-04-091,400$2.08
$2.91kBuy
Evert B. SchimmelpenninkPresident CEO and Secretary2025-03-074,200$1.04
$4.37kBuy
Shawn OlssonChief Commercial Officer2024-12-163,333$2.08
$6.93kBuy
Evert B. SchimmelpenninkPresident CEO and Secretary2024-07-2245,000$1.04
$46.80kBuy

1 of 1

LENZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LENZ insiders and whales buy or sell their stock.

LENZ Shareholders

What type of owners hold Lenz Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC30.34%8,538,446$247.61MInsider
Samsara Biocapital LP30.32%8,534,820$247.51MInsider
Ra Capital Management LP14.85%4,178,823$121.19MInstitution
Alpha Wave Ventures GP Ltd12.83%3,612,211$104.75MInsider
Alpha Wave Global LP12.83%3,612,211$104.75MInstitution
Versant Venture Capital VI LP10.46%2,943,361$85.36MInsider
Davis Jerel6.07%1,707,719$49.52MInsider
Versant Venture Capital VII LP5.68%1,598,789$46.36MInsider
Paradigm Biocapital Advisors LP5.37%1,511,932$43.85MInstitution
Vanguard Group Inc4.26%1,199,462$34.78MInstitution

1 of 3

LENZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LENZ40.93%59.07%Net SellingNet Selling
COGT90.95%9.05%Net Buying
IMNM88.41%7.69%Net BuyingNet Buying
AVBP73.48%26.52%Net Buying
QURE87.80%12.20%Net Selling
View Top Biotech Stocks

Lenz Therapeutics Stock Ownership FAQ

Who owns Lenz Therapeutics?

Lenz Therapeutics (NASDAQ: LENZ) is owned by 74.88% institutional shareholders, 108.07% Lenz Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Lenz Therapeutics shareholder, owning 8.54M shares representing 30.34% of the company. Ecor1 Capital LLC's Lenz Therapeutics shares are currently valued at $247.61M.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.